Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-05-16Clinical Trial Update: A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response [NA]
A completed clinical trial evaluated motivational interviewing and interactive voice response to reduce hospital readmissions in patients wi…
-
FDA approval · 2013-05-14FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for carvedilol from Aurobindo Pharma Limited, granting approval of an additional generic carvedi…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ? [NA]
A terminated clinical trial evaluating humidification methods (Heat and Moisture Exchanger vs Heated Humidifier) during noninvasive ventilat…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial) [Phase 2, Phase 3]
METIS tested methotrexate therapy effects on physical capacity in patients with ischemic heart failure. The Phase 2/3 trial is completed wit…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease [Phase 1]
Phase 1 trial evaluating CLP with and without spironolactone in heart failure patients with chronic kidney disease has completed and results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-05-07FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for carvedilol from Dr. Reddy's Laboratories Limited (ANDA) to modify or update the approved product…
-
FDA approval · 2013-05-07FDA Approved: CARVEDILOL — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for carvedilol submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Symphony: The Implantable Counter Pulsation Device (CPD) Safety and Feasibility Trial [Phase 1, Phase 2]
This clinical trial update covers the safety and feasibility assessment of the Symphony implantable counter pulsation device in chronic hear…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: OptiVol® Care Pathway [Phase 4]
Phase 4 clinical trial update for Medtronic's OptiVol Care Pathway in heart failure. The study completed and results were posted in 2013.
-
CLINICAL_TRIALS withdrawal · 2013-05-03Clinical Trial Update: Investigating the Role of Impella 2.5 System in Acutely Decompensated Chronic Heart Failure Patients [NA]
The clinical trial evaluating the Impella 2.5 System for acutely decompensated chronic heart failure has been terminated.
-
FDA approval · 2013-05-03FDA Approved: CANDESARTAN CILEXETIL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for candesartan cilexetil (generic) by Mylan Pharmaceuticals Inc., authorizing the marketing of a gene…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients
A clinical trial evaluating the clinical course of dyspnea in patients with acute heart failure has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Validating PROMIS Instruments in Congestive Heart Failure Patients Receiving a Heart Transplant
This completed clinical trial evaluated validating PROMIS health outcome instruments in congestive heart failure patients receiving a heart …
-
FDA approval · 2013-04-29FDA Approved: QUINAPRIL — Original Application (Aurobindo Pharma Limited)
FDA approves the original generic application for quinapril hydrochloride (quinapril HCl) from Aurobindo Pharma Limited.
-
FDA approval · 2013-04-26FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure [Phase 4]
Phase 4 single-dose pharmacodynamic study comparing torasemide extended-release 10 mg, torasemide immediate-release 10 mg, and furosemide im…
-
CLINICAL_TRIALS other · 2013-04-23Clinical Trial Update: Epiphrenic III Pilot Trial [NA]
Clinical trial update for Epiphrenic III Pilot Trial sponsored by Luzerner Kantonsspital, related to heart failure; the current status is un…
-
FDA approval · 2013-04-17FDA Approved: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare's supplemental application for dobutamine hydrochloride in dextrose. The approval covers the dobutamine hydro…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation [NA]
Completed clinical trial evaluating acoustic cardiography for assessing heart function and the role of phrenic nerve stimulation in heart fa…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery [NA]
A completed clinical trial evaluated diaphragmatic stimulation in patients with severe heart failure following heart surgery. The entry conf…
-
CLINICAL_TRIALS research · 2013-04-11Clinical Trial Update: Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure
This clinical trial investigates how body composition affects the pharmacokinetics of bisoprolol and ramipril in patients with chronic heart…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients [NA]
This clinical trial update reports results from the CardioMEMS heart sensor showing improved outcomes for patients with NYHA Class III heart…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide [Phase 1]
This Phase 1 study evaluated the safety, pharmacokinetics and pharmacodynamics of COR-1, a beta-1 receptor-targeting cyclopeptide, in heart …
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study [Phase 3]
Phase 3 pilot trial comparing AV node ablation with pacemaker therapy to drug therapy for atrial fibrillation was terminated, with results p…
-
CLINICAL_TRIALS research · 2013-04-01Clinical Trial Update: Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg [Phase 1]
A Phase 1 study comparing the pharmacokinetic characteristics and safety of Dilatrend sustained-release 32 mg capsules versus Dilatrend 25 m…